产品名称

TGX 221

产品货号

Axon 1417 CAS [663619-89-4] MF C21H24N4O2MW 364.44 Purity: 99% Soluble in DMSO Description Potent and specific PI3K p110β inhibitor References Certificates Categories Extra info SP Jackson et al. PI 3-kinase p110b: A new target for antithrombotic therapy. Nature Medicine 2005, 11(5), 507-514. BT Hennessy et al. Exploiting the PI3K/AKT pathway for cancer drug discovery. Nature Reviews Drug Discovery 2005, 4988-1004. AM Condliffe et al. Sequential activation of class IB and class IA PI3K is important for the primed respiratory burst of human but not murine neutrophils. Blood 2005, 106, 1432-1440. Certificate of Analysis Material Safety Data Sheet Cell Signaling & Oncology PI3K PI3K-Akt-mTOR EC 2.7.1.153 PI3K inhibitor (p110 β specific) Chemical name 7-methyl-2-morpholin-4-yl-9-(1-phenylaminoethyl)-pyrido[1,2-a]-pyrimidin-4-one Parent CAS No. [663619-89-4] Order Size Unit Price Stock 2 mg €70.00 In Stock

产品价格

现货询价，电话：010-67529703

产品规格

产品品牌

axonmedchem

产品概述

产品详情

TGX 221

Based on 8 reference(s) in Google Scholar 9 10 8

Axon 1417

CAS [663619-89-4]

MF C21H24N4O2
MW 364.44

Purity: 99%
Soluble in DMSO

TGX 221

Description

Potent and specific PI3K p110β inhibitor

SP Jackson et al. PI 3-kinase p110b: A new target for antithrombotic therapy. Nature Medicine 2005, 11(5), 507-514.

BT Hennessy et al. Exploiting the PI3K/AKT pathway for cancer drug discovery. Nature Reviews Drug Discovery 2005, 4988-1004.

AM Condliffe et al. Sequential activation of class IB and class IA PI3K is important for the primed respiratory burst of human but not murine neutrophils. Blood 2005, 106, 1432-1440.

PI3K inhibitor (p110 β specific)

Chemical name

7-methyl-2-morpholin-4-yl-9-(1-phenylaminoethyl)-pyrido[1,2-a]-pyrimidin-4-one

Parent CAS No.

[663619-89-4]

产品资料